

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.96488460 |
| 2 | cell adhesion mediated by integrin (GO:0033627) | 3.63820211 |
| 3 | low-density lipoprotein particle clearance (GO:0034383) | 3.63325173 |
| 4 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.49428387 |
| 5 | hypotonic response (GO:0006971) | 3.39941517 |
| 6 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.39652840 |
| 7 | hemidesmosome assembly (GO:0031581) | 3.37208708 |
| 8 | pinocytosis (GO:0006907) | 3.26826313 |
| 9 | protein localization to endosome (GO:0036010) | 3.23668222 |
| 10 | platelet degranulation (GO:0002576) | 3.11804087 |
| 11 | positive regulation of receptor recycling (GO:0001921) | 3.07572678 |
| 12 | angiogenesis involved in wound healing (GO:0060055) | 2.99568341 |
| 13 | negative regulation of fatty acid transport (GO:2000192) | 2.98109741 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.97871443 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.97871443 |
| 16 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.97511586 |
| 17 | stress fiber assembly (GO:0043149) | 2.96870179 |
| 18 | apoptotic cell clearance (GO:0043277) | 2.96377106 |
| 19 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.93964726 |
| 20 | protein heterotrimerization (GO:0070208) | 2.93288921 |
| 21 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.88820030 |
| 22 | barbed-end actin filament capping (GO:0051016) | 2.86477758 |
| 23 | axon extension involved in axon guidance (GO:0048846) | 2.85690445 |
| 24 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.85690445 |
| 25 | definitive hemopoiesis (GO:0060216) | 2.83597468 |
| 26 | skin morphogenesis (GO:0043589) | 2.82890360 |
| 27 | endodermal cell differentiation (GO:0035987) | 2.82272313 |
| 28 | adherens junction assembly (GO:0034333) | 2.80495647 |
| 29 | cellular response to vitamin D (GO:0071305) | 2.80146514 |
| 30 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.80127821 |
| 31 | fibrinolysis (GO:0042730) | 2.79761736 |
| 32 | focal adhesion assembly (GO:0048041) | 2.79523687 |
| 33 | cell-substrate adherens junction assembly (GO:0007045) | 2.79523687 |
| 34 | wound healing, spreading of epidermal cells (GO:0035313) | 2.78760297 |
| 35 | negative regulation of fibrinolysis (GO:0051918) | 2.77805232 |
| 36 | collagen fibril organization (GO:0030199) | 2.77526307 |
| 37 | chondrocyte proliferation (GO:0035988) | 2.76250096 |
| 38 | regulation of early endosome to late endosome transport (GO:2000641) | 2.75817956 |
| 39 | basement membrane organization (GO:0071711) | 2.75770462 |
| 40 | blood coagulation, intrinsic pathway (GO:0007597) | 2.74565761 |
| 41 | cellular response to vitamin (GO:0071295) | 2.74155233 |
| 42 | alpha-linolenic acid metabolic process (GO:0036109) | 2.70335322 |
| 43 | Golgi transport vesicle coating (GO:0048200) | 2.69072990 |
| 44 | COPI coating of Golgi vesicle (GO:0048205) | 2.69072990 |
| 45 | embryonic process involved in female pregnancy (GO:0060136) | 2.68032840 |
| 46 | negative regulation of platelet activation (GO:0010544) | 2.64794531 |
| 47 | thrombin receptor signaling pathway (GO:0070493) | 2.63919921 |
| 48 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.63682139 |
| 49 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.61897627 |
| 50 | positive regulation of macrophage differentiation (GO:0045651) | 2.61728146 |
| 51 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.59584895 |
| 52 | platelet aggregation (GO:0070527) | 2.57384599 |
| 53 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.57380773 |
| 54 | mRNA transcription (GO:0009299) | 2.57308696 |
| 55 | * positive regulation of blood coagulation (GO:0030194) | 2.56258631 |
| 56 | * positive regulation of hemostasis (GO:1900048) | 2.56258631 |
| 57 | germ cell migration (GO:0008354) | 2.55817344 |
| 58 | negative regulation of lipid transport (GO:0032369) | 2.55727099 |
| 59 | extracellular fibril organization (GO:0043206) | 2.55453444 |
| 60 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.54999760 |
| 61 | positive regulation of extracellular matrix organization (GO:1903055) | 2.53793754 |
| 62 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.52266467 |
| 63 | fibril organization (GO:0097435) | 2.52038603 |
| 64 | renal filtration (GO:0097205) | 2.51719502 |
| 65 | response to interferon-alpha (GO:0035455) | 2.50639520 |
| 66 | negative regulation of blood coagulation (GO:0030195) | 2.50116144 |
| 67 | negative regulation of hemostasis (GO:1900047) | 2.50116144 |
| 68 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.48613320 |
| 69 | substrate-dependent cell migration (GO:0006929) | 2.48299578 |
| 70 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.47675293 |
| 71 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.46613607 |
| 72 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.46495507 |
| 73 | * positive regulation of coagulation (GO:0050820) | 2.46472639 |
| 74 | mesodermal cell differentiation (GO:0048333) | 2.44692383 |
| 75 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.44670244 |
| 76 | hepatocyte apoptotic process (GO:0097284) | 2.44154189 |
| 77 | glomerular basement membrane development (GO:0032836) | 2.43606065 |
| 78 | protein carboxylation (GO:0018214) | 2.43329180 |
| 79 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.43329180 |
| 80 | epithelial cell-cell adhesion (GO:0090136) | 2.40863768 |
| 81 | negative regulation of coagulation (GO:0050819) | 2.40051349 |
| 82 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.39227378 |
| 83 | regulation of platelet activation (GO:0010543) | 2.39018923 |
| 84 | regulation of lipoprotein metabolic process (GO:0050746) | 2.38117636 |
| 85 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.37697935 |
| 86 | cell-substrate junction assembly (GO:0007044) | 2.37635357 |
| 87 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.37280715 |
| 88 | positive regulation of histone deacetylation (GO:0031065) | 2.37135430 |
| 89 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.36643144 |
| 90 | plasma lipoprotein particle clearance (GO:0034381) | 2.36500246 |
| 91 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.36418583 |
| 92 | establishment of endothelial barrier (GO:0061028) | 2.36393383 |
| 93 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.35800257 |
| 94 | angiotensin maturation (GO:0002003) | 2.35018834 |
| 95 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.34494725 |
| 96 | negative regulation of wound healing (GO:0061045) | 2.33821784 |
| 97 | response to laminar fluid shear stress (GO:0034616) | 2.33716576 |
| 98 | multicellular organismal catabolic process (GO:0044243) | 2.33611677 |
| 99 | muscle cell migration (GO:0014812) | 2.32957140 |
| 100 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.32344360 |
| 101 | virion attachment to host cell (GO:0019062) | 2.31880887 |
| 102 | adhesion of symbiont to host cell (GO:0044650) | 2.31880887 |
| 103 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.31510148 |
| 104 | desmosome organization (GO:0002934) | 2.31248547 |
| 105 | negative regulation of anoikis (GO:2000811) | 2.30960764 |
| 106 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.30388466 |
| 107 | response to muramyl dipeptide (GO:0032495) | 2.29850142 |
| 108 | modulation by symbiont of host defense response (GO:0052031) | 2.29656257 |
| 109 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.29656257 |
| 110 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.29656257 |
| 111 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.29656257 |
| 112 | modulation by symbiont of host immune response (GO:0052553) | 2.29656257 |
| 113 | positive regulation by symbiont of host defense response (GO:0052509) | 2.29656257 |
| 114 | fibroblast migration (GO:0010761) | 2.29551263 |
| 115 | regulation of platelet aggregation (GO:0090330) | 2.29351113 |
| 116 | lymph vessel development (GO:0001945) | 2.28867096 |
| 117 | pattern specification involved in kidney development (GO:0061004) | 2.28708387 |
| 118 | collagen metabolic process (GO:0032963) | 2.28518878 |
| 119 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.28179216 |
| 120 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.27622143 |
| 121 | multicellular organismal metabolic process (GO:0044236) | 2.26835089 |
| 122 | wound healing, spreading of cells (GO:0044319) | 2.26543931 |
| 123 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.26512050 |
| 124 | triglyceride catabolic process (GO:0019433) | 2.26294532 |
| 125 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.25275695 |
| 126 | response to fluid shear stress (GO:0034405) | 2.25258632 |
| 127 | blood vessel maturation (GO:0001955) | 2.25188981 |
| 128 | hyaluronan catabolic process (GO:0030214) | 2.25024908 |
| 129 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.22437536 |
| 130 | surfactant homeostasis (GO:0043129) | 2.20937614 |
| 131 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.20836234 |
| 132 | protein localization to cell surface (GO:0034394) | 2.20817031 |
| 133 | adhesion of symbiont to host (GO:0044406) | 2.20670374 |
| 134 | collagen catabolic process (GO:0030574) | 2.19789694 |
| 135 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.19641868 |
| 136 | glomerular visceral epithelial cell development (GO:0072015) | 2.19627205 |
| 137 | cell-matrix adhesion (GO:0007160) | 2.19567948 |
| 138 | positive regulation of osteoblast proliferation (GO:0033690) | 2.19170391 |
| 139 | regulation of extracellular matrix disassembly (GO:0010715) | 2.18604928 |
| 140 | endothelium development (GO:0003158) | 2.18556582 |
| 141 | neutrophil activation involved in immune response (GO:0002283) | 2.18555438 |
| 142 | regulation of protein activation cascade (GO:2000257) | 2.18422377 |
| 143 | positive regulation of adherens junction organization (GO:1903393) | 2.18416342 |
| 144 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 2.18205244 |
| 145 | glomerular filtration (GO:0003094) | 2.17965851 |
| 146 | regulation of complement activation (GO:0030449) | 2.17825103 |
| 147 | membrane raft organization (GO:0031579) | 2.17725867 |
| 148 | cortical actin cytoskeleton organization (GO:0030866) | 2.17706108 |
| 149 | regulation of cholesterol homeostasis (GO:2000188) | 2.17393734 |
| 150 | neutral lipid catabolic process (GO:0046461) | 2.17284625 |
| 151 | acylglycerol catabolic process (GO:0046464) | 2.17284625 |
| 152 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.17182347 |
| 153 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.17174573 |
| 154 | low-density lipoprotein particle remodeling (GO:0034374) | 2.16963100 |
| 155 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.16812199 |
| 156 | peptide catabolic process (GO:0043171) | 2.16737594 |
| 157 | membrane protein ectodomain proteolysis (GO:0006509) | 2.16682264 |
| 158 | regulation of integrin activation (GO:0033623) | 2.16642997 |
| 159 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.16622876 |
| 160 | positive regulation of cell junction assembly (GO:1901890) | 2.16134422 |
| 161 | positive regulation of focal adhesion assembly (GO:0051894) | 2.16134422 |
| 162 | phospholipid homeostasis (GO:0055091) | 2.15842360 |
| 163 | endothelial tube morphogenesis (GO:0061154) | 2.15719908 |
| 164 | morphogenesis of an endothelium (GO:0003159) | 2.15719908 |
| 165 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.14551218 |
| 166 | regulation of cholesterol storage (GO:0010885) | 2.14522370 |
| 167 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.13761593 |
| 168 | leukocyte cell-cell adhesion (GO:0007159) | 2.12598407 |
| 169 | regulation of monocyte chemotaxis (GO:0090025) | 2.11716149 |
| 170 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.10878993 |
| 171 | radial glial cell differentiation (GO:0060019) | 2.10833888 |
| 172 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.10748277 |
| 173 | integrin-mediated signaling pathway (GO:0007229) | 2.10508827 |
| 174 | negative regulation of phagocytosis (GO:0050765) | 2.10292793 |
| 175 | positive regulation of p38MAPK cascade (GO:1900745) | 2.09807670 |
| 176 | myoblast migration (GO:0051451) | 2.09627573 |
| 177 | coronary vasculature morphogenesis (GO:0060977) | 2.08862869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.14134210 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.80766607 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.65076021 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.49514223 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.32464804 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.24923558 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.05750153 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.92489212 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.86996756 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.44441833 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.42404457 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.40067138 |
| 13 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.28388074 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.27717693 |
| 15 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.26408437 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.24798688 |
| 17 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.23363063 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22955350 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.22795418 |
| 20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.22057772 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.11661361 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.10284135 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.08898890 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.04630620 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.02995814 |
| 26 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 2.02180556 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.01079113 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.00257755 |
| 29 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.94744980 |
| 30 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.94019615 |
| 31 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.93239813 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.92480953 |
| 33 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.90473301 |
| 34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89702691 |
| 35 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.88752164 |
| 36 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.88752164 |
| 37 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.86664589 |
| 38 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.81394794 |
| 39 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.81044037 |
| 40 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.78324763 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.72187232 |
| 42 | CJUN_26792858_Chip-Seq_BT549_Human | 1.72098682 |
| 43 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.71898797 |
| 44 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.70014272 |
| 45 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.68535192 |
| 46 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.68120107 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.67948444 |
| 48 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.67236960 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.61467371 |
| 50 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.59796901 |
| 51 | * MAF_26560356_Chip-Seq_TH1_Human | 1.58644413 |
| 52 | MYB_26560356_Chip-Seq_TH2_Human | 1.58623198 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.57631763 |
| 54 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.55965536 |
| 55 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.55494634 |
| 56 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.51352717 |
| 57 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.51352717 |
| 58 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.50741463 |
| 59 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.50287743 |
| 60 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.49270841 |
| 61 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49052755 |
| 62 | MYC_22102868_ChIP-Seq_BL_Human | 1.48349862 |
| 63 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.47305017 |
| 64 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.46768191 |
| 65 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.46633656 |
| 66 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.43817795 |
| 67 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.43817795 |
| 68 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.40367178 |
| 69 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.40103960 |
| 70 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.39324401 |
| 71 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.37738345 |
| 72 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.37506897 |
| 73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.37504147 |
| 74 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.36691847 |
| 75 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36341131 |
| 76 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35365828 |
| 77 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.35271385 |
| 78 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.34907629 |
| 79 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.34068545 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33512792 |
| 81 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33214352 |
| 82 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32823946 |
| 83 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32526123 |
| 84 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.32110827 |
| 85 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.31738493 |
| 86 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.29893132 |
| 87 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.29446165 |
| 88 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.29356997 |
| 89 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29226966 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24527283 |
| 91 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.24451618 |
| 92 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.23550792 |
| 93 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.23180405 |
| 94 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.21740490 |
| 95 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.20539077 |
| 96 | MYB_26560356_Chip-Seq_TH1_Human | 1.20381903 |
| 97 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.19773395 |
| 98 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.19557312 |
| 99 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.19480548 |
| 100 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18974950 |
| 101 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17875039 |
| 102 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17129082 |
| 103 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15955285 |
| 104 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.15518511 |
| 105 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.14474713 |
| 106 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.14170898 |
| 107 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13635615 |
| 108 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.13486194 |
| 109 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.12957028 |
| 110 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.12926716 |
| 111 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12559806 |
| 112 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.12024932 |
| 113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11415608 |
| 114 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10168700 |
| 115 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.09470559 |
| 116 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.09230913 |
| 117 | ATF3_27146783_Chip-Seq_COLON_Human | 1.09227617 |
| 118 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.08927848 |
| 119 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08879590 |
| 120 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06656865 |
| 121 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06316819 |
| 122 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.04734382 |
| 123 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.03994171 |
| 124 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.03875800 |
| 125 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03326706 |
| 126 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01190938 |
| 127 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00250274 |
| 128 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99604118 |
| 129 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98026190 |
| 130 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96502911 |
| 131 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95910604 |
| 132 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95710389 |
| 133 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.94822720 |
| 134 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91675761 |
| 135 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91034807 |
| 136 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90799426 |
| 137 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.90736658 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.34538307 |
| 2 | MP0006054_spinal_hemorrhage | 3.16653591 |
| 3 | MP0003300_gastrointestinal_ulcer | 2.85885160 |
| 4 | MP0005275_abnormal_skin_tensile | 2.73314702 |
| 5 | MP0004272_abnormal_basement_membrane | 2.57420918 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.50547934 |
| 7 | MP0003279_aneurysm | 2.42234395 |
| 8 | MP0001958_emphysema | 2.37115259 |
| 9 | MP0003566_abnormal_cell_adhesion | 2.21822849 |
| 10 | MP0005503_abnormal_tendon_morphology | 2.16741056 |
| 11 | MP0003950_abnormal_plasma_membrane | 2.13214287 |
| 12 | MP0003724_increased_susceptibility_to | 2.07275780 |
| 13 | MP0008004_abnormal_stomach_pH | 2.06633297 |
| 14 | MP0010352_gastrointestinal_tract_polyps | 2.01915371 |
| 15 | MP0001879_abnormal_lymphatic_vessel | 1.96717831 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 1.94710817 |
| 17 | MP0002166_altered_tumor_susceptibility | 1.73773057 |
| 18 | MP0005666_abnormal_adipose_tissue | 1.72830972 |
| 19 | MP0009278_abnormal_bone_marrow | 1.71329787 |
| 20 | MP0004084_abnormal_cardiac_muscle | 1.70647213 |
| 21 | MP0003091_abnormal_cell_migration | 1.67664163 |
| 22 | MP0005023_abnormal_wound_healing | 1.66322997 |
| 23 | MP0003436_decreased_susceptibility_to | 1.62467906 |
| 24 | MP0010368_abnormal_lymphatic_system | 1.62392515 |
| 25 | MP0002877_abnormal_melanocyte_morpholog | 1.61392343 |
| 26 | MP0005451_abnormal_body_composition | 1.59206482 |
| 27 | MP0000767_abnormal_smooth_muscle | 1.57893607 |
| 28 | MP0009840_abnormal_foam_cell | 1.56469996 |
| 29 | MP0003941_abnormal_skin_development | 1.54694249 |
| 30 | MP0002060_abnormal_skin_morphology | 1.53598270 |
| 31 | MP0004130_abnormal_muscle_cell | 1.50728767 |
| 32 | MP0006138_congestive_heart_failure | 1.50687363 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.45554438 |
| 34 | MP0003045_fibrosis | 1.45410448 |
| 35 | MP0005623_abnormal_meninges_morphology | 1.44495244 |
| 36 | MP0002139_abnormal_hepatobiliary_system | 1.43084158 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.42010611 |
| 38 | MP0004510_myositis | 1.41247508 |
| 39 | MP0002933_joint_inflammation | 1.40694593 |
| 40 | MP0004808_abnormal_hematopoietic_stem | 1.39732164 |
| 41 | MP0005670_abnormal_white_adipose | 1.39617489 |
| 42 | MP0004036_abnormal_muscle_relaxation | 1.39255127 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.37895959 |
| 44 | MP0004947_skin_inflammation | 1.37517573 |
| 45 | MP0000858_altered_metastatic_potential | 1.35988471 |
| 46 | MP0003828_pulmonary_edema | 1.33913363 |
| 47 | MP0003303_peritoneal_inflammation | 1.33399423 |
| 48 | MP0000751_myopathy | 1.31817250 |
| 49 | MP0005257_abnormal_intraocular_pressure | 1.31221487 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.28832509 |
| 51 | MP0001835_abnormal_antigen_presentation | 1.28528054 |
| 52 | MP0005375_adipose_tissue_phenotype | 1.28455462 |
| 53 | MP0002006_tumorigenesis | 1.28401596 |
| 54 | MP0003868_abnormal_feces_composition | 1.28312809 |
| 55 | MP0000685_abnormal_immune_system | 1.27698539 |
| 56 | MP0005360_urolithiasis | 1.26749148 |
| 57 | MP0009384_cardiac_valve_regurgitation | 1.26322425 |
| 58 | MP0003448_altered_tumor_morphology | 1.25411597 |
| 59 | MP0000733_abnormal_muscle_development | 1.22538540 |
| 60 | MP0001661_extended_life_span | 1.22278655 |
| 61 | MP0000490_abnormal_crypts_of | 1.22152044 |
| 62 | MP0005076_abnormal_cell_differentiation | 1.21150222 |
| 63 | MP0004233_abnormal_muscle_weight | 1.18783311 |
| 64 | MP0002148_abnormal_hypersensitivity_rea | 1.15433087 |
| 65 | MP0005390_skeleton_phenotype | 1.14446680 |
| 66 | MP0002419_abnormal_innate_immunity | 1.14387910 |
| 67 | MP0005000_abnormal_immune_tolerance | 1.12692247 |
| 68 | MP0002452_abnormal_antigen_presenting | 1.10633635 |
| 69 | MP0002971_abnormal_brown_adipose | 1.10167189 |
| 70 | MP0001790_abnormal_immune_system | 1.08826229 |
| 71 | MP0005387_immune_system_phenotype | 1.08826229 |
| 72 | MP0005365_abnormal_bile_salt | 1.07411232 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 1.07183131 |
| 74 | MP0001545_abnormal_hematopoietic_system | 1.07183131 |
| 75 | MP0005174_abnormal_tail_pigmentation | 1.06835031 |
| 76 | MP0004087_abnormal_muscle_fiber | 1.05964999 |
| 77 | MP0005058_abnormal_lysosome_morphology | 1.05500002 |
| 78 | MP0000343_altered_response_to | 1.05218913 |
| 79 | MP0002405_respiratory_system_inflammati | 1.05155105 |
| 80 | MP0005165_increased_susceptibility_to | 1.04570955 |
| 81 | MP0005464_abnormal_platelet_physiology | 1.04547564 |
| 82 | MP0010234_abnormal_vibrissa_follicle | 1.03328040 |
| 83 | MP0009785_altered_susceptibility_to | 1.02990858 |
| 84 | MP0000465_gastrointestinal_hemorrhage | 1.01823676 |
| 85 | MP0002896_abnormal_bone_mineralization | 1.01796674 |
| 86 | MP0005508_abnormal_skeleton_morphology | 1.01507654 |
| 87 | MP0008260_abnormal_autophagy | 0.99498350 |
| 88 | MP0005025_abnormal_response_to | 0.99143304 |
| 89 | MP0000249_abnormal_blood_vessel | 0.98024567 |
| 90 | MP0009379_abnormal_foot_pigmentation | 0.94256177 |
| 91 | MP0002420_abnormal_adaptive_immunity | 0.93689286 |
| 92 | MP0001819_abnormal_immune_cell | 0.93319046 |
| 93 | MP0003795_abnormal_bone_structure | 0.93301117 |
| 94 | MP0004264_abnormal_extraembryonic_tissu | 0.93011327 |
| 95 | MP0001800_abnormal_humoral_immune | 0.92808632 |
| 96 | MP0000569_abnormal_digit_pigmentation | 0.91647082 |
| 97 | MP0005164_abnormal_response_to | 0.89329694 |
| 98 | MP0010329_abnormal_lipoprotein_level | 0.88830807 |
| 99 | MP0002972_abnormal_cardiac_muscle | 0.88405341 |
| 100 | MP0010630_abnormal_cardiac_muscle | 0.88009120 |
| 101 | MP0002723_abnormal_immune_serum | 0.86638827 |
| 102 | MP0001873_stomach_inflammation | 0.86389872 |
| 103 | MP0000013_abnormal_adipose_tissue | 0.86335135 |
| 104 | MP0000537_abnormal_urethra_morphology | 0.85782645 |
| 105 | MP0001845_abnormal_inflammatory_respons | 0.85206970 |
| 106 | MP0003183_abnormal_peptide_metabolism | 0.84811670 |
| 107 | MP0001849_ear_inflammation | 0.84754897 |
| 108 | MP0000759_abnormal_skeletal_muscle | 0.84680203 |
| 109 | MP0002796_impaired_skin_barrier | 0.84496360 |
| 110 | MP0009780_abnormal_chondrocyte_physiolo | 0.83184191 |
| 111 | MP0001614_abnormal_blood_vessel | 0.82828153 |
| 112 | MP0008775_abnormal_heart_ventricle | 0.82393579 |
| 113 | MP0002332_abnormal_exercise_endurance | 0.82088729 |
| 114 | MP0001243_abnormal_dermal_layer | 0.81862119 |
| 115 | MP0001666_abnormal_nutrient_absorption | 0.81683452 |
| 116 | MP0003656_abnormal_erythrocyte_physiolo | 0.80618213 |
| 117 | MP0003453_abnormal_keratinocyte_physiol | 0.80096630 |
| 118 | MP0005595_abnormal_vascular_smooth | 0.79806525 |
| 119 | MP0003866_abnormal_defecation | 0.79700965 |
| 120 | MP0002009_preneoplasia | 0.79219711 |
| 121 | MP0002295_abnormal_pulmonary_circulatio | 0.79081139 |
| 122 | MP0002925_abnormal_cardiovascular_devel | 0.78344144 |
| 123 | MP0001851_eye_inflammation | 0.76583962 |
| 124 | MP0002113_abnormal_skeleton_development | 0.76542409 |
| 125 | MP0003763_abnormal_thymus_physiology | 0.76239691 |
| 126 | MP0009333_abnormal_splenocyte_physiolog | 0.74882629 |
| 127 | MP0002168_other_aberrant_phenotype | 0.74530541 |
| 128 | MP0002398_abnormal_bone_marrow | 0.74252817 |
| 129 | MP0000477_abnormal_intestine_morphology | 0.73718757 |
| 130 | MP0009115_abnormal_fat_cell | 0.72921954 |
| 131 | MP0000747_muscle_weakness | 0.72219549 |
| 132 | MP0005085_abnormal_gallbladder_physiolo | 0.72062240 |
| 133 | MP0002128_abnormal_blood_circulation | 0.71949655 |
| 134 | MP0005620_abnormal_muscle_contractility | 0.71927613 |
| 135 | MP0005385_cardiovascular_system_phenoty | 0.71581864 |
| 136 | MP0001544_abnormal_cardiovascular_syste | 0.71581864 |
| 137 | MP0000538_abnormal_urinary_bladder | 0.71019647 |
| 138 | MP0004185_abnormal_adipocyte_glucose | 0.70553434 |
| 139 | MP0005621_abnormal_cell_physiology | 0.70422023 |
| 140 | MP0000716_abnormal_immune_system | 0.70189804 |
| 141 | MP0005330_cardiomyopathy | 0.70138871 |
| 142 | MP0005409_darkened_coat_color | 0.68851959 |
| 143 | MP0005501_abnormal_skin_physiology | 0.67940327 |
| 144 | MP0000749_muscle_degeneration | 0.67657306 |
| 145 | MP0001915_intracranial_hemorrhage | 0.66463121 |
| 146 | MP0004883_abnormal_blood_vessel | 0.65605890 |
| 147 | MP0000003_abnormal_adipose_tissue | 0.65478103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 4.77994827 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.45341814 |
| 3 | Menorrhagia (HP:0000132) | 4.18662839 |
| 4 | Ankle contracture (HP:0006466) | 4.01260647 |
| 5 | Atrophic scars (HP:0001075) | 3.66479735 |
| 6 | Aortic dissection (HP:0002647) | 3.63557297 |
| 7 | Aortic aneurysm (HP:0004942) | 3.59392998 |
| 8 | Cerebral aneurysm (HP:0004944) | 3.55211577 |
| 9 | Cervical subluxation (HP:0003308) | 3.48697654 |
| 10 | Prolonged bleeding time (HP:0003010) | 3.31635159 |
| 11 | Purpura (HP:0000979) | 3.09559836 |
| 12 | Gingival bleeding (HP:0000225) | 3.03556333 |
| 13 | Fragile skin (HP:0001030) | 3.02123064 |
| 14 | Myocardial infarction (HP:0001658) | 2.99978206 |
| 15 | Hematochezia (HP:0002573) | 2.98807702 |
| 16 | Shallow orbits (HP:0000586) | 2.95658715 |
| 17 | Broad metatarsal (HP:0001783) | 2.78333246 |
| 18 | Increased connective tissue (HP:0009025) | 2.75916017 |
| 19 | Epistaxis (HP:0000421) | 2.68658839 |
| 20 | Dilatation of the ascending aorta (HP:0005111) | 2.68331302 |
| 21 | Vascular tortuosity (HP:0004948) | 2.67307227 |
| 22 | Increased variability in muscle fiber diameter (HP:0003557) | 2.61555932 |
| 23 | Peritonitis (HP:0002586) | 2.60320418 |
| 24 | Mitral stenosis (HP:0001718) | 2.58764112 |
| 25 | Soft skin (HP:0000977) | 2.56885625 |
| 26 | Spondylolisthesis (HP:0003302) | 2.54779797 |
| 27 | Deep venous thrombosis (HP:0002625) | 2.52663573 |
| 28 | Osteolytic defects of the hand bones (HP:0009699) | 2.49562273 |
| 29 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.49562273 |
| 30 | Interstitial pulmonary disease (HP:0006530) | 2.45910537 |
| 31 | Vertebral compression fractures (HP:0002953) | 2.43677131 |
| 32 | Arterial tortuosity (HP:0005116) | 2.40978933 |
| 33 | Spinal rigidity (HP:0003306) | 2.40775160 |
| 34 | Bladder diverticulum (HP:0000015) | 2.38282111 |
| 35 | Petechiae (HP:0000967) | 2.36316901 |
| 36 | Distal lower limb amyotrophy (HP:0008944) | 2.35538854 |
| 37 | Thin bony cortex (HP:0002753) | 2.31658783 |
| 38 | Syringomyelia (HP:0003396) | 2.29302352 |
| 39 | Spinal cord lesions (HP:0100561) | 2.29302352 |
| 40 | Nemaline bodies (HP:0003798) | 2.26924563 |
| 41 | Wormian bones (HP:0002645) | 2.26648598 |
| 42 | Abnormal platelet function (HP:0011869) | 2.25003902 |
| 43 | Impaired platelet aggregation (HP:0003540) | 2.25003902 |
| 44 | Mitral valve prolapse (HP:0001634) | 2.24132351 |
| 45 | Autoimmune thrombocytopenia (HP:0001973) | 2.21541728 |
| 46 | * Abnormality of the common coagulation pathway (HP:0010990) | 2.18617066 |
| 47 | Right ventricular cardiomyopathy (HP:0011663) | 2.18017615 |
| 48 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.17924164 |
| 49 | Recurrent abscess formation (HP:0002722) | 2.17489555 |
| 50 | Broad face (HP:0000283) | 2.16198193 |
| 51 | Distal lower limb muscle weakness (HP:0009053) | 2.15336632 |
| 52 | Spontaneous hematomas (HP:0007420) | 2.14905939 |
| 53 | Type 1 muscle fiber predominance (HP:0003803) | 2.14293305 |
| 54 | Muscle fiber inclusion bodies (HP:0100299) | 2.11788691 |
| 55 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.11533018 |
| 56 | Mitral regurgitation (HP:0001653) | 2.11334628 |
| 57 | Abnormality of complement system (HP:0005339) | 2.09701112 |
| 58 | Increased density of long bones (HP:0006392) | 2.07563230 |
| 59 | Wrist flexion contracture (HP:0001239) | 2.06247707 |
| 60 | Complement deficiency (HP:0004431) | 2.05706202 |
| 61 | Exercise-induced myalgia (HP:0003738) | 2.02884663 |
| 62 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.00118649 |
| 63 | Cardiovascular calcification (HP:0011915) | 1.99250330 |
| 64 | Striae distensae (HP:0001065) | 1.99076850 |
| 65 | Aneurysm (HP:0002617) | 1.98610778 |
| 66 | Flat acetabular roof (HP:0003180) | 1.98423270 |
| 67 | Xanthomatosis (HP:0000991) | 1.97988494 |
| 68 | Joint hemorrhage (HP:0005261) | 1.97055139 |
| 69 | Esophageal varix (HP:0002040) | 1.95862020 |
| 70 | Conjunctival telangiectasia (HP:0000524) | 1.93327076 |
| 71 | Vacuolated lymphocytes (HP:0001922) | 1.92393405 |
| 72 | Hemorrhage of the eye (HP:0011885) | 1.92030295 |
| 73 | Milia (HP:0001056) | 1.91972685 |
| 74 | Follicular hyperkeratosis (HP:0007502) | 1.91647734 |
| 75 | Hyperlipoproteinemia (HP:0010980) | 1.91201990 |
| 76 | Eczematoid dermatitis (HP:0000976) | 1.91026154 |
| 77 | Asymmetric septal hypertrophy (HP:0001670) | 1.90762142 |
| 78 | Aplasia cutis congenita (HP:0001057) | 1.90554924 |
| 79 | Back pain (HP:0003418) | 1.89856154 |
| 80 | Ankyloglossia (HP:0010296) | 1.89509728 |
| 81 | Blue sclerae (HP:0000592) | 1.89502530 |
| 82 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.89037418 |
| 83 | Short nail (HP:0001799) | 1.87038233 |
| 84 | Mucopolysacchariduria (HP:0008155) | 1.86583231 |
| 85 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.86583231 |
| 86 | Bicuspid aortic valve (HP:0001647) | 1.86540213 |
| 87 | Abnormal delivery (HP:0001787) | 1.85474818 |
| 88 | Asymmetry of the thorax (HP:0001555) | 1.85181976 |
| 89 | Cellulitis (HP:0100658) | 1.84373640 |
| 90 | Polycythemia (HP:0001901) | 1.83371143 |
| 91 | Hyporeflexia of lower limbs (HP:0002600) | 1.83123677 |
| 92 | Systemic lupus erythematosus (HP:0002725) | 1.82880798 |
| 93 | Mesangial abnormality (HP:0001966) | 1.82368967 |
| 94 | Radial bowing (HP:0002986) | 1.81444019 |
| 95 | Subacute progressive viral hepatitis (HP:0006572) | 1.81334932 |
| 96 | Abnormality of the nasal mucosa (HP:0000433) | 1.80555893 |
| 97 | Increased cerebral lipofuscin (HP:0011813) | 1.80279024 |
| 98 | Myositis (HP:0100614) | 1.79878317 |
| 99 | Bruising susceptibility (HP:0000978) | 1.79774018 |
| 100 | Rectal prolapse (HP:0002035) | 1.79033833 |
| 101 | Round ear (HP:0100830) | 1.76580360 |
| 102 | Elbow flexion contracture (HP:0002987) | 1.76407402 |
| 103 | Amyloidosis (HP:0011034) | 1.75650708 |
| 104 | Ureteral obstruction (HP:0006000) | 1.75515437 |
| 105 | Abnormality of oral frenula (HP:0000190) | 1.74767933 |
| 106 | Knee flexion contracture (HP:0006380) | 1.74151684 |
| 107 | Abnormality of the peritoneum (HP:0002585) | 1.73968166 |
| 108 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.73520324 |
| 109 | Hypoplasia of the iris (HP:0007676) | 1.73275286 |
| 110 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.73052345 |
| 111 | Abnormality of carpal bone ossification (HP:0006257) | 1.72865238 |
| 112 | Papillary thyroid carcinoma (HP:0002895) | 1.72740235 |
| 113 | Dysostosis multiplex (HP:0000943) | 1.72733442 |
| 114 | Abnormality of the neuromuscular junction (HP:0003398) | 1.71381434 |
| 115 | Fatigable weakness (HP:0003473) | 1.71381434 |
| 116 | Vascular calcification (HP:0004934) | 1.70575678 |
| 117 | Abnormality of the Achilles tendon (HP:0005109) | 1.70495480 |
| 118 | Genu recurvatum (HP:0002816) | 1.70234369 |
| 119 | Tetraparesis (HP:0002273) | 1.69865997 |
| 120 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.68655327 |
| 121 | Abnormal ossification of hand bones (HP:0005921) | 1.68492968 |
| 122 | Hypercholesterolemia (HP:0003124) | 1.68371648 |
| 123 | Skin nodule (HP:0200036) | 1.68330901 |
| 124 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.68006737 |
| 125 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.68006737 |
| 126 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.68006737 |
| 127 | Muscle fiber splitting (HP:0003555) | 1.67547038 |
| 128 | Camptodactyly of toe (HP:0001836) | 1.66770790 |
| 129 | Abnormality of the acetabulum (HP:0003170) | 1.66042144 |
| 130 | Hypoalphalipoproteinemia (HP:0003233) | 1.65992911 |
| 131 | Ureteral stenosis (HP:0000071) | 1.64764565 |
| 132 | Persistence of primary teeth (HP:0006335) | 1.64520565 |
| 133 | Thoracolumbar scoliosis (HP:0002944) | 1.64403078 |
| 134 | Aortic regurgitation (HP:0001659) | 1.63893780 |
| 135 | Bowel diverticulosis (HP:0005222) | 1.63768718 |
| 136 | Neonatal short-limb short stature (HP:0008921) | 1.63556110 |
| 137 | Nonimmune hydrops fetalis (HP:0001790) | 1.63049392 |
| 138 | Abnormality of the calcaneus (HP:0008364) | 1.62853058 |
| 139 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.62819979 |
| 140 | Abnormal platelet volume (HP:0011876) | 1.61496436 |
| 141 | Lower limb amyotrophy (HP:0007210) | 1.61239281 |
| 142 | Increased IgE level (HP:0003212) | 1.59876098 |
| 143 | Easy fatigability (HP:0003388) | 1.59449469 |
| 144 | Biconcave vertebral bodies (HP:0004586) | 1.59058626 |
| 145 | Abnormality of skull ossification (HP:0002703) | 1.58056807 |
| 146 | Tibial bowing (HP:0002982) | 1.57430662 |
| 147 | Recurrent viral infections (HP:0004429) | 1.57222368 |
| 148 | Ulnar bowing (HP:0003031) | 1.56969837 |
| 149 | Overgrowth (HP:0001548) | 1.56932909 |
| 150 | Insidious onset (HP:0003587) | 1.56652479 |
| 151 | Termporal pattern (HP:0011008) | 1.56652479 |
| 152 | Joint stiffness (HP:0001387) | 1.56290246 |
| 153 | Joint laxity (HP:0001388) | 1.56184185 |
| 154 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.55092245 |
| 155 | Increased mean platelet volume (HP:0011877) | 1.54630013 |
| 156 | Craniofacial hyperostosis (HP:0004493) | 1.53829611 |
| 157 | Hypothermia (HP:0002045) | 1.53759308 |
| 158 | Slender build (HP:0001533) | 1.53161516 |
| 159 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.52816520 |
| 160 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.52728368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 2.81735653 |
| 2 | ERN1 | 2.79079481 |
| 3 | TGFBR2 | 2.64426484 |
| 4 | TTN | 2.58553895 |
| 5 | MST4 | 2.36891266 |
| 6 | DMPK | 2.19263642 |
| 7 | NLK | 2.15410522 |
| 8 | LRRK2 | 2.03282770 |
| 9 | PDGFRA | 1.98659766 |
| 10 | LATS2 | 1.92618603 |
| 11 | STK10 | 1.87771465 |
| 12 | PRPF4B | 1.80029942 |
| 13 | PTK6 | 1.79585109 |
| 14 | EPHB2 | 1.72955960 |
| 15 | CDK12 | 1.70430749 |
| 16 | RIPK1 | 1.68898969 |
| 17 | TIE1 | 1.67438624 |
| 18 | FRK | 1.64061672 |
| 19 | KIT | 1.60984387 |
| 20 | PKN2 | 1.60421010 |
| 21 | PAK4 | 1.58281940 |
| 22 | DDR2 | 1.56246626 |
| 23 | TGFBR1 | 1.50500023 |
| 24 | TRPM7 | 1.47742446 |
| 25 | EEF2K | 1.46141640 |
| 26 | ICK | 1.43483357 |
| 27 | EPHA2 | 1.41867936 |
| 28 | ZAP70 | 1.40715799 |
| 29 | MAP3K10 | 1.38038922 |
| 30 | EPHB1 | 1.37209440 |
| 31 | EPHA3 | 1.35355426 |
| 32 | FLT3 | 1.35309123 |
| 33 | MST1R | 1.35297788 |
| 34 | KDR | 1.30927688 |
| 35 | JAK3 | 1.30264368 |
| 36 | TYK2 | 1.28417368 |
| 37 | PIM2 | 1.28310683 |
| 38 | TBK1 | 1.26989094 |
| 39 | MAP4K1 | 1.25455724 |
| 40 | OBSCN | 1.25241191 |
| 41 | PRKG2 | 1.22875529 |
| 42 | PAK2 | 1.22854326 |
| 43 | FER | 1.20183521 |
| 44 | PDGFRB | 1.18199483 |
| 45 | MAP2K3 | 1.17606829 |
| 46 | BLK | 1.15988337 |
| 47 | STK24 | 1.14951417 |
| 48 | MOS | 1.13283352 |
| 49 | KSR2 | 1.12715031 |
| 50 | CDK6 | 1.09651344 |
| 51 | CAMKK2 | 1.09508493 |
| 52 | RPS6KA4 | 1.08727482 |
| 53 | TEC | 1.07842816 |
| 54 | AKT3 | 1.07823271 |
| 55 | IRAK3 | 1.06571037 |
| 56 | NME2 | 1.06152887 |
| 57 | CDC42BPA | 1.05465317 |
| 58 | NEK9 | 1.04603964 |
| 59 | PTK2 | 1.03187677 |
| 60 | FGFR4 | 1.01799319 |
| 61 | RIPK4 | 1.01539198 |
| 62 | FGFR3 | 1.00693281 |
| 63 | ITK | 0.99822669 |
| 64 | CAMK1D | 0.99693575 |
| 65 | RET | 0.97961652 |
| 66 | SIK1 | 0.96615875 |
| 67 | MAP3K6 | 0.96613768 |
| 68 | CSK | 0.96519128 |
| 69 | TNIK | 0.96117216 |
| 70 | JAK1 | 0.95312528 |
| 71 | MAP3K2 | 0.95033450 |
| 72 | MATK | 0.94271971 |
| 73 | MELK | 0.94088365 |
| 74 | MAP3K13 | 0.93613770 |
| 75 | MAP3K14 | 0.93480897 |
| 76 | NUAK1 | 0.93372561 |
| 77 | CDK9 | 0.90707360 |
| 78 | PDPK1 | 0.89015690 |
| 79 | BMPR2 | 0.87614224 |
| 80 | NTRK1 | 0.87346504 |
| 81 | IKBKB | 0.86099247 |
| 82 | CSF1R | 0.85696056 |
| 83 | BMX | 0.84373178 |
| 84 | LATS1 | 0.80745276 |
| 85 | IRAK4 | 0.80734727 |
| 86 | MAP3K7 | 0.79794268 |
| 87 | ERBB4 | 0.79056676 |
| 88 | CHUK | 0.78124282 |
| 89 | PRKAA2 | 0.77625583 |
| 90 | FGR | 0.77090532 |
| 91 | EIF2AK1 | 0.76494601 |
| 92 | SGK3 | 0.76381221 |
| 93 | HCK | 0.75206782 |
| 94 | BTK | 0.73468623 |
| 95 | MAP2K2 | 0.73026478 |
| 96 | PRKD2 | 0.71995662 |
| 97 | ILK | 0.67322604 |
| 98 | ARAF | 0.66511083 |
| 99 | PTK2B | 0.66503044 |
| 100 | STK3 | 0.66376544 |
| 101 | MAP3K3 | 0.64342801 |
| 102 | STK38 | 0.64321419 |
| 103 | PIK3CG | 0.64063046 |
| 104 | MAPKAPK3 | 0.64010348 |
| 105 | TAOK2 | 0.62451409 |
| 106 | HIPK2 | 0.62361821 |
| 107 | STK38L | 0.62341826 |
| 108 | SMG1 | 0.62246305 |
| 109 | PIM1 | 0.61976367 |
| 110 | MET | 0.61634222 |
| 111 | TAOK3 | 0.61213535 |
| 112 | IKBKE | 0.61204594 |
| 113 | MAP3K1 | 0.60880434 |
| 114 | GSK3A | 0.59716841 |
| 115 | SCYL2 | 0.57853261 |
| 116 | RPS6KB2 | 0.57154483 |
| 117 | BRSK2 | 0.56221271 |
| 118 | LCK | 0.53663759 |
| 119 | PDK1 | 0.52683552 |
| 120 | MTOR | 0.52376086 |
| 121 | MAPK11 | 0.51022662 |
| 122 | CLK1 | 0.50782662 |
| 123 | JAK2 | 0.49345314 |
| 124 | PRKD1 | 0.49154379 |
| 125 | CAMK1G | 0.48992152 |
| 126 | BRD4 | 0.48544613 |
| 127 | MAPK7 | 0.48296836 |
| 128 | TESK1 | 0.47756778 |
| 129 | MAP2K1 | 0.47495815 |
| 130 | YES1 | 0.47187288 |
| 131 | LMTK2 | 0.47055382 |
| 132 | IGF1R | 0.46638501 |
| 133 | KSR1 | 0.45556010 |
| 134 | MAPKAPK2 | 0.44107554 |
| 135 | GRK6 | 0.43938127 |
| 136 | MYLK | 0.42704808 |
| 137 | ABL2 | 0.42605342 |
| 138 | DYRK1B | 0.42466308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.13411057 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.11313566 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 1.86976840 |
| 4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.82457223 |
| 5 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.82342168 |
| 6 | Focal adhesion_Homo sapiens_hsa04510 | 1.82305615 |
| 7 | Adherens junction_Homo sapiens_hsa04520 | 1.81439175 |
| 8 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.81358101 |
| 9 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.78144141 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.72786119 |
| 11 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.68650228 |
| 12 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.65573425 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.63089759 |
| 14 | Malaria_Homo sapiens_hsa05144 | 1.58662648 |
| 15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56188781 |
| 16 | Thyroid cancer_Homo sapiens_hsa05216 | 1.54936442 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.54228802 |
| 18 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.49674952 |
| 19 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.48988030 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.48306973 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.43606117 |
| 22 | Amoebiasis_Homo sapiens_hsa05146 | 1.43412563 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.42443363 |
| 24 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.36094877 |
| 25 | Shigellosis_Homo sapiens_hsa05131 | 1.35963091 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.33390441 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31680279 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.30860708 |
| 29 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.28733863 |
| 30 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.25161058 |
| 31 | Measles_Homo sapiens_hsa05162 | 1.24848875 |
| 32 | Platelet activation_Homo sapiens_hsa04611 | 1.24221528 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 1.22715001 |
| 34 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.21237294 |
| 35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.20849287 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18283617 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.18072147 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15306171 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.15052961 |
| 40 | Bladder cancer_Homo sapiens_hsa05219 | 1.14107289 |
| 41 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.13040516 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.12162691 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.11593765 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.11348289 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.09043581 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08830091 |
| 47 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.06855130 |
| 48 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.05381073 |
| 49 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.05321588 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.04786230 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 1.04347662 |
| 52 | Tuberculosis_Homo sapiens_hsa05152 | 1.02229776 |
| 53 | Prostate cancer_Homo sapiens_hsa05215 | 1.00869894 |
| 54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.99485641 |
| 55 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.98140797 |
| 56 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.96636557 |
| 57 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.96128534 |
| 58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.95807568 |
| 59 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.95277996 |
| 60 | Legionellosis_Homo sapiens_hsa05134 | 0.95145922 |
| 61 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.94907515 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.93970769 |
| 63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93878378 |
| 64 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.93358034 |
| 65 | Mineral absorption_Homo sapiens_hsa04978 | 0.93078979 |
| 66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92165573 |
| 67 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.91693117 |
| 68 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.91256349 |
| 69 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.89718589 |
| 70 | Pathways in cancer_Homo sapiens_hsa05200 | 0.88765257 |
| 71 | Influenza A_Homo sapiens_hsa05164 | 0.88730687 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85533616 |
| 73 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.84927905 |
| 74 | Colorectal cancer_Homo sapiens_hsa05210 | 0.84335752 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.84186331 |
| 76 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.82766702 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.82518071 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.81876413 |
| 79 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81576800 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.81349886 |
| 81 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.80844712 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.80808377 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80503539 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.80247818 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.79914440 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 0.79796786 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.77279293 |
| 88 | Glioma_Homo sapiens_hsa05214 | 0.77250765 |
| 89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77180127 |
| 90 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.77142115 |
| 91 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.77111171 |
| 92 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.75785739 |
| 93 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.75730338 |
| 94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.75674715 |
| 95 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75187453 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75088259 |
| 97 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.74747455 |
| 98 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.74311824 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73100703 |
| 100 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.73008423 |
| 101 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.71971762 |
| 102 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.70323598 |
| 103 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69181253 |
| 104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.68624132 |
| 105 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.68009390 |
| 106 | Melanoma_Homo sapiens_hsa05218 | 0.66878327 |
| 107 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66057841 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.66003220 |
| 109 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.65844045 |
| 110 | Bile secretion_Homo sapiens_hsa04976 | 0.64842141 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.64274148 |
| 112 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.63378602 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63162853 |
| 114 | Endocytosis_Homo sapiens_hsa04144 | 0.62257885 |
| 115 | Gap junction_Homo sapiens_hsa04540 | 0.61269496 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60866906 |
| 117 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.59790908 |
| 118 | Insulin resistance_Homo sapiens_hsa04931 | 0.59246897 |
| 119 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.59076969 |
| 120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58326752 |
| 121 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57033562 |
| 122 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56900758 |
| 123 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56512078 |
| 124 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.56502450 |
| 125 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55636557 |
| 126 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53535098 |
| 127 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52654983 |
| 128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51558735 |
| 129 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.51051955 |
| 130 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50628741 |
| 131 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50231313 |
| 132 | Tight junction_Homo sapiens_hsa04530 | 0.49467773 |
| 133 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49056583 |
| 134 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49048528 |

